Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation.
Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD. Bunch TJ, et al. Among authors: crandall bg. J Cardiovasc Electrophysiol. 2016 Feb;27(2):141-6. doi: 10.1111/jce.12849. Epub 2015 Nov 20. J Cardiovasc Electrophysiol. 2016. PMID: 26443666
Frequency of elevation of C-reactive protein in atrial fibrillation.
Anderson JL, Allen Maycock CA, Lappé DL, Crandall BG, Horne BD, Bair TL, Morris SR, Li Q, Muhlestein JB; Intermountain Heart Collaborative Study group. Anderson JL, et al. Among authors: crandall bg. Am J Cardiol. 2004 Nov 15;94(10):1255-9. doi: 10.1016/j.amjcard.2004.07.108. Am J Cardiol. 2004. PMID: 15541240
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Day JD, et al. Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470697 Clinical Trial.
Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD. Bunch TJ, et al. Among authors: crandall bg. J Cardiovasc Electrophysiol. 2009 Sep;20(9):988-93. doi: 10.1111/j.1540-8167.2009.01481.x. Epub 2009 May 15. J Cardiovasc Electrophysiol. 2009. PMID: 19473299 Clinical Trial.
53 results